Latest News
|
20 May 2013
0 Likes 
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US NYTimes Reports Chinese Hackers Going After, Among Other Things, Clinical Trials Results
Read More...
Latest News
|
17 May 2013
0 Likes
Hello and welcome to a new edition of Five in Focus, our Friday recap of the five most important, interesting, riveting or ground-breaking stories of the week.FDA's Big Week for Device Guidance and
Read More...
Latest News
|
17 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US Is the Hatch-Waxman Act Flawed and Should the Supreme Court Fix It? (Becker's Hospital
Read More...
Latest News
|
16 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: Special Edition Dirty Medicine: The Epic Story of Criminal Fraud at Ranbaxy (Fortune)
Read More...
Latest News
|
15 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US Fraud Cases' Impact on Ranbaxy May Climb as High as $1 Billion (India Times) Confusion
Read More...
Latest News
|
14 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US US Government Files Morning-After Pill Appeal (AP) (WSJ) (CBS) (The Hill) (SCOTUS Blog)
Read More...
Regulatory Update
|
13 May 2013
0 Likes
The Committee on Social Security and Family of Brazil’s House of Representatives held a hearing on 9 May 2013 on the scope of regulatory authority of Brazil’s National Health Surveillance Agency
Read More...
Latest News
|
10 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US FDA Begins Gearing up to Hire Huge Number of New Employees to Meet GDUFA Targets (FDA) J&J
Read More...
Latest News
|
8 May 2013
0 Likes
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US Judge in NYC Rips Opposition to Plan B Order, Hamburg Cites Troubling Precedent (AP)
Read More...
Latest News
|
1 May 2013
2 Likes
The US Food and Drug Administration (FDA) recently set out to get patients and patient groups considerably more involved in the regulatory process through its Patient Network, a new website and
Read More...